|1.||Gehl, Julie: 2 articles (01/2015 - 09/2013)|
|2.||Spanggaard, Iben: 2 articles (01/2015 - 09/2013)|
|3.||Cemazar, Maja: 2 articles (11/2013 - 09/2013)|
|4.||Sersa, Gregor: 2 articles (11/2013 - 09/2013)|
|5.||Bosnjak, M: 1 article (07/2015)|
|6.||Kamensek, U: 1 article (07/2015)|
|7.||Markelc, B: 1 article (07/2015)|
|8.||Turk, B: 1 article (07/2015)|
|9.||Bouquet, C: 1 article (07/2015)|
|10.||Zavrsnik, J: 1 article (07/2015)|
|1.||Melanoma (Melanoma, Malignant)
11/01/2013 - "The study indicates that antiproliferative and antimetastatic biological responses to gene electrotransfer of plasmid AMEP in murine melanoma cells were dependent on the integrin quantity on melanoma cells and not on the expression level of AMEP. "
09/01/2013 - "This first-in-man study on electrotransfer of plasmid AMEP into cutaneous melanoma shows that the procedure and drug are safe and that local transfection was obtained."
09/01/2013 - "This first-in-man phase I study investigated safety and tolerability of intratumoral plasmid AMEP electrotransfer into cutaneous metastatic melanoma. "
09/01/2013 - "Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study."
07/01/2015 - "Gene therapy with Plasmid AMEP (antiangiogenic metargidin peptide) has recently been studied as a potential targeted therapy for melanoma. "
|2.||Mixed Conductive-Sensorineural Hearing Loss
|3.||Central Sleep Apnea (Central Sleep Apnea Syndrome)
|1.||Prostheses and Implants (Prosthesis)